1
|
Sesé L, Gille T, Pau G, Dessimond B, Uzunhan Y, Bouvry D, Hervé A, Didier M, Kort F, Freynet O, Rotenberg C, Jeny F, Khamis W, Hindre R, Maesano CN, Planes C, Nunes H, Annesi-Maesano I. Low-cost air quality portable sensors and their potential use in respiratory health. Int J Tuberc Lung Dis 2023; 27:803-809. [PMID: 37880892 DOI: 10.5588/ijtld.23.0197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2023] Open
Abstract
Air pollution is an environmental risk for the general population and for patients with various diseases, particularly respiratory diseases. Little data are available on personal exposure, but the recent emergence of low-cost air quality sensors (LCSs) should enable a better understanding of the health impacts of air pollution at the individual level. However, the reliability and accuracy of most sensors in the market have not been established, and a thorough understanding of their strengths and limitations is needed. We therefore conducted a review to address the following questions: 1) What is an LCS and what is the extent of its possible application? 2) Is the data obtained a reliable indicator of exposure? 3) What are the advantages and disadvantages of LCSs? 4) Could LCSs be useful in investigating the impact of air pollution on respiratory health? Further studies are needed to promote the use of LCS in research settings and among respiratory patients. This will allow us to monitor exposure levels, provide alerts and study the respiratory effects of individual-level air pollution.
Collapse
Affiliation(s)
- L Sesé
- Department of Physiology and Functional Explorations, Assistance Publique-Hôpitaux de Paris (AP-HP), and, Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - T Gille
- Department of Physiology and Functional Explorations, Assistance Publique-Hôpitaux de Paris (AP-HP), and, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - G Pau
- Department of Computer Science and Engineering University of Bologna, Bologna, Italy
| | - B Dessimond
- Institute Desbrest of Epidemiology and Public Health, University of Montpellier and INSERM
| | - Y Uzunhan
- Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - D Bouvry
- Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - A Hervé
- Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - M Didier
- Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - F Kort
- Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - O Freynet
- Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - C Rotenberg
- Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - F Jeny
- Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - W Khamis
- Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - R Hindre
- Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - C N Maesano
- Department of Computer Science and Engineering University of Bologna, Bologna, Italy
| | - C Planes
- Department of Physiology and Functional Explorations, Assistance Publique-Hôpitaux de Paris (AP-HP), and, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - H Nunes
- Department of Pneumology, Centre Constitutif de Référence des Maladies pulmonaires rares, AP-HP, Hôpital Avicenne, Bobigny, Unité mixte de recherche 1272 'Hypoxia and the Lung', Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne Paris Nord, Bobigny
| | - I Annesi-Maesano
- Institute Desbrest of Epidemiology and Public Health, University of Montpellier and INSERM, Departement of Allergic and Respiratory Diseases, Montpellier University Hospital, Montpellier, France
| |
Collapse
|
2
|
Santos Portela AM, Radu DM, Onorati I, Peretti M, Freynet O, Uzunhan Y, Jerbi S, Martinod E. [Interventionnal bronchoscopy for the treatment of tracheobronchomalacia]. Rev Mal Respir 2023; 40:700-715. [PMID: 37714754 DOI: 10.1016/j.rmr.2023.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2023] [Accepted: 07/18/2023] [Indexed: 09/17/2023]
Abstract
Tracheobronchomalacia is usually characterized by more than 50% expiratory narrowing in diameter of the trachea and the bronchi. The expiratory collapse includes two entities: (1) the TBM related to the weakness of the cartilaginous rings, and (2) the Excessive Dynamic Airway Collapse (EDAC) due to the excessive bulging of the posterior membrane. Patients have nonspecific respiratory symptoms like dyspnea and cough. Diagnosis is confirmed by dynamic tests: flexible bronchoscopy and/or computed tomographic scan of the chest. There are different forms of tracheobronchomalacia in adults: primary (genetic, idiopathic) or secondary to trauma, tracheotomy, intubation, surgery, transplantation, emphysema, infection, inflammation, chronic bronchitis, extrinsic compression; or undiagnosed in childhood vascular rings. Some management algorithms have been proposed, but no specific recommendation was established. Only symptomatic patients should be treated. Medical treatments and noninvasive positive pressure ventilation should be the first line therapy, after evaluation of various quality measures (functional status, performance status, dyspnea and quality of life scores). If symptoms persist, therapeutic bronchoscopy permits: (1) patient's selection by stent trial to determine whether patient benefit for surgical airway stabilization; (2) malacic airways stenting in patients who are not surgical candidates, improving QOL despite a high complication rate; (3) the management of stent-related complication (obstruction, plugging, migration granuloma); (4) alternative therapeutics like thermo-ablative solution. Lasty, the development of new types of stents would reduce the complication rates. These different options remained discussed.
Collapse
Affiliation(s)
- A M Santos Portela
- Département de chirurgie thoracique et vasculaire, faculté de médecine SMBH, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Seine-Saint-Denis, hôpital Avicenne, université Sorbonne Paris Nord, Bobigny, France
| | - D M Radu
- Département de chirurgie thoracique et vasculaire, faculté de médecine SMBH, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Seine-Saint-Denis, hôpital Avicenne, université Sorbonne Paris Nord, Bobigny, France
| | - I Onorati
- Département de chirurgie thoracique et vasculaire, faculté de médecine SMBH, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Seine-Saint-Denis, hôpital Avicenne, université Sorbonne Paris Nord, Bobigny, France
| | - M Peretti
- Département de chirurgie thoracique et vasculaire, faculté de médecine SMBH, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Seine-Saint-Denis, hôpital Avicenne, université Sorbonne Paris Nord, Bobigny, France
| | - O Freynet
- Département de pneumologie, faculté de Médecine SMBH, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Seine-Saint-Denis, hôpital Avicenne, université Sorbonne Paris Nord, Bobigny, France
| | - Y Uzunhan
- Département de pneumologie, faculté de Médecine SMBH, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Seine-Saint-Denis, hôpital Avicenne, université Sorbonne Paris Nord, Bobigny, France
| | - S Jerbi
- Département d'anesthésie, faculté de médecine SMBH, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Seine-Saint-Denis, hôpital Avicenne, université Sorbonne Paris Nord, Bobigny, France
| | - E Martinod
- Département de chirurgie thoracique et vasculaire, faculté de médecine SMBH, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Seine-Saint-Denis, hôpital Avicenne, université Sorbonne Paris Nord, Bobigny, France.
| |
Collapse
|
3
|
Sese L, Nunes H, Cottin V, Israel-Biet D, Crestani B, Guillot Dudoret S, Cadranel J, Wallaert B, Tazi A, Maître B, Prévot G, Marchand-Adam S, Hirschi S, Dury S, Giraud V, Gondouin A, Bonniaud P, Traclet J, Juvin K, Borie R, Carton Z, Caliez J, Freynet O, Gille T, Planes C, Valeyre D, Uzunhan Y. Gender differences in idiopathic pulmonary fibrosis: Are men and women equal or not? Rev Mal Respir 2021. [DOI: 10.1016/j.rmr.2021.02.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
4
|
Tandjaoui-Lambiotte Y, Gonzalez F, Boubaya M, Freynet O, Clec H C, Bonnet N, Van Der Meersch G, Oziel J, Huang C, Uzunhan Y, Brillet PY, Poirson F, Martin O, Ahmed P, Ebstein N, Karoubi P, Gaudry S, Nunes H, Cohen Y. Two-year follow-up of 196 interstitial lung disease patients after ICU stay. Int J Tuberc Lung Dis 2021; 25:199-205. [PMID: 33688808 DOI: 10.5588/ijtld.20.0706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
OBJECTIVE: Interstitial lung diseases (ILDs) are associated with poor prognosis in the intensive care unit (ICU). We aimed to assess factors associated with hospital mortality in ILD patients admitted to the ICU and to investigate long-term outcome.MATERIAL AND METHODS: This was a retrospective study in a teaching hospital specialised in ILD management. Patients with ILD who were hospitalised in the ICU between 2000 and 2014 were included. Independent predictors of hospital mortality were identified using logistic regression.RESULTS: A total of 196 ILD patients were admitted to the ICU during the study period. Overall hospital mortality was 55%. Two years after ICU admission, 70 (36%) patients were still alive. Of the 196 patients, 108 (55%) required invasive mechanical ventilation, of whom 21 (20%) were discharged alive from hospital. Acute exacerbation of ILD and multi-organ failure were highly associated with hospital mortality (OR 5.4, 95% CI 1.9-15.5 and OR 12.6, 95% CI 4.9-32.5, respectively).CONCLUSION: Hospital mortality among ILD patients hospitalised in the ICU was high, but even where invasive mechanical ventilation was required, a substantial number of patients were discharged alive from hospital. Multi-organ failure could lead to major ethical concerns.
Collapse
Affiliation(s)
- Y Tandjaoui-Lambiotte
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, Institut national de la santé et de la recherche médicale (INSERM) Hypoxie & Poumon, Bobigny
| | - F Gonzalez
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny
| | - M Boubaya
- Unité de Recherche Clinique, Hôpital Avicenne, Bobigny
| | - O Freynet
- Service de Pneumologie, Hôpital Avicenne, Bobigny
| | - C Clec H
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny
| | - N Bonnet
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, Université Paris XIII, Sorbonne Paris Cité, Paris
| | - G Van Der Meersch
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny
| | - J Oziel
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny
| | - C Huang
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny
| | - Y Uzunhan
- Institut national de la santé et de la recherche médicale (INSERM) Hypoxie & Poumon, Bobigny, Service de Pneumologie, Hôpital Avicenne, Bobigny, Université Paris XIII, Sorbonne Paris Cité, Paris
| | - P-Y Brillet
- Université Paris XIII, Sorbonne Paris Cité, Paris, Service de Radiologie, Hôpital Avicenne, Bobigny
| | - F Poirson
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny
| | - O Martin
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, Université Paris XIII, Sorbonne Paris Cité, Paris
| | - P Ahmed
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny
| | - N Ebstein
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, Université Paris XIII, Sorbonne Paris Cité, Paris
| | - P Karoubi
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny
| | - S Gaudry
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, Université Paris XIII, Sorbonne Paris Cité, Paris, Unité mixte de Recherche S1155, Remodeling and Repair of Renal Tissue, INSERM, Hôpital Tenon, F-75020, Paris
| | - H Nunes
- Institut national de la santé et de la recherche médicale (INSERM) Hypoxie & Poumon, Bobigny, Service de Pneumologie, Hôpital Avicenne, Bobigny, Université Paris XIII, Sorbonne Paris Cité, Paris
| | - Y Cohen
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, Université Paris XIII, Sorbonne Paris Cité, Paris, Unité 942, F-75010, INSERM, Paris, France
| |
Collapse
|
5
|
Daccord C, Cottin V, Prévot G, Uzunhan Y, Mornex JF, Bonniaud P, Borie R, Briault A, Collonge-Rame MA, Crestani B, Devouassoux G, Freynet O, Gondouin A, Hauss PA, Khouatra C, Leroy S, Marchand-Adam S, Marquette C, Montani D, Naccache JM, Nadeau G, Poulalhon N, Reynaud-Gaubert M, Salaun M, Wallaert B, Cordier JF, Faouzi M, Lazor R. Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients. Orphanet J Rare Dis 2020; 15:120. [PMID: 32448321 PMCID: PMC7245949 DOI: 10.1186/s13023-020-01402-y] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2019] [Accepted: 05/06/2020] [Indexed: 12/21/2022] Open
Abstract
Background Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder caused by mutations in the FLCN gene coding for folliculin. Its clinical expression includes cutaneous fibrofolliculomas, renal tumors, multiple pulmonary cysts, and recurrent spontaneous pneumothoraces. Data on lung function in BHD are scarce and it is not known whether lung function declines over time. We retrospectively assessed lung function at baseline and during follow-up in 96 patients with BHD. Results Ninety-five percent of BHD patients had multiple pulmonary cysts on computed tomography and 59% had experienced at least one pneumothorax. Mean values of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, and total lung capacity were normal at baseline. Mean (standard deviation) residual volume (RV) was moderately increased to 116 (36) %pred at baseline, and RV was elevated > 120%pred in 41% of cases. Mean (standard deviation) carbon monoxide transfer factor (DLco) was moderately decreased to 85 (18) %pred at baseline, and DLco was decreased < 80%pred in 33% of cases. When adjusted for age, gender, smoking and history of pleurodesis, lung function parameters did not significantly decline over a follow-up period of 6 years. Conclusions Cystic lung disease in BHD does not affect respiratory function at baseline except for slightly increased RV and reduced DLco. No significant deterioration of lung function occurs in BHD over a follow-up period of 6 years.
Collapse
Affiliation(s)
- C Daccord
- Service de pneumologie, Centre hospitalier universitaire vaudois, Université de Lausanne, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland
| | - V Cottin
- Service de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1, UMR754 INRA, IVPC, Lyon, France
| | - G Prévot
- Service de pneumologie, Centre hospitalier universitaire de Toulouse, Toulouse, France
| | - Y Uzunhan
- Service de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Avicenne, INSERM UMR 1272, Université Paris 13, Bobigny, France
| | - J F Mornex
- Service de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1, UMR754 INRA, IVPC, Lyon, France
| | - P Bonniaud
- Service de Pneumologie et Soins Intensifs Respiratoires, Centre hospitalier universitaire Dijon/Bourgogne, Université Bourgogne-Franche Comté, INSERM U123-1, Dijon, France
| | - R Borie
- Service de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Bichat - Claude Bernard, Paris, France
| | - A Briault
- Service de pneumologie, Centre hospitalier universitaire de Grenoble, Grenoble, France
| | - M A Collonge-Rame
- Service de génétique biologique - histologie, UF cytogénétique, UF consultations d'oncogénétique, Centre hospitalier universitaire de Besançon, Besançon, France
| | - B Crestani
- Service de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Bichat - Claude Bernard, Paris, France
| | - G Devouassoux
- Service de pneumologie, Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Lyon, France
| | - O Freynet
- Service de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Avicenne, INSERM UMR 1272, Université Paris 13, Bobigny, France
| | - A Gondouin
- Service de pneumologie, Centre hospitalier universitaire de Besançon, Besançon, France
| | - P A Hauss
- Centre hospitalier intercommunal Elbeuf - Louviers - Val de Reuil, Elbeuf, France
| | - C Khouatra
- Service de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1, UMR754 INRA, IVPC, Lyon, France
| | - S Leroy
- Service de pneumologie, Université Côte d'Azur, Centre hospitalier universitaire de Nice, CNRS, INSERM, FHU OncoAge, Nice, France
| | - S Marchand-Adam
- Service de pneumologie, Centre hospitalier universitaire de Tours, Tours, France
| | - C Marquette
- Service de pneumologie, Université Côte d'Azur, Centre hospitalier universitaire de Nice, CNRS, INSERM, FHU OncoAge, Nice, France
| | - D Montani
- Service de Pneumologie, Université Paris-Sud, Assistance Publique Hôpitaux de Paris, INSERM UMR S999, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
| | - J M Naccache
- Service de Pneumologie, Site constitutif du Centre de référence des maladies pulmonaires rares OrphaLung, Assistance Publique Hôpitaux de Paris, Hôpital Tenon, Paris, France
| | - G Nadeau
- Centre hospitalier Métropole Savoie, UF de Génétique chromosomique, Chambéry, France
| | - N Poulalhon
- Service de dermatologie, Hospices Civils de Lyon, Centre hospitalier Lyon-Sud, Lyon, France
| | - M Reynaud-Gaubert
- Service de pneumologie, Centre de compétences des maladies pulmonaires rares, Assistance Publique Hôpitaux de Marseille, Centre hospitalier universitaire de Marseille, Aix Marseille Université, Marseille, France
| | - M Salaun
- Service de pneumologie, Centre hospitalier universitaire de Rouen, Rouen, France
| | - B Wallaert
- Service de pneumologie, Centre hospitalier universitaire de Lille, Lille, France
| | - J F Cordier
- Service de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1, UMR754 INRA, IVPC, Lyon, France
| | - M Faouzi
- Division de biostatistique, Centre universitaire de médecine générale et santé publique (Unisanté), Université de Lausanne, Lausanne, Switzerland
| | - R Lazor
- Service de pneumologie, Centre hospitalier universitaire vaudois, Université de Lausanne, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
| | | |
Collapse
|
6
|
Sesé L, Jeny F, Uzunhan Y, Khamis W, Freynet O, Valeyre D, Bernaudin JF, Annesi-Maesano I, Nunes H. [The effect of air pollution in diffuse interstitial lung disease]. Rev Mal Respir 2020; 37:389-398. [PMID: 32278507 DOI: 10.1016/j.rmr.2020.02.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2019] [Accepted: 02/09/2020] [Indexed: 11/30/2022]
Abstract
Few studies have examined the effects of air pollution in diffuse interstitial lung disease and they have focused on small numbers of patients. Most data are available in idiopathic pulmonary fibrosis and studies suggest that the level of exposure to pollutants may influence the development of acute exacerbations (ozone and NO2), their incidence (NO2), decline in respiratory function (PM10) and death (PM10 and PM2.5). Several studies show an increase in the incidence of rheumatoid arthritis in people living near busy roads. In systemic scleroderma, hypersensitivity pneumonitis and sarcoidosis although negative effects of pollution have been reported the data are insufficient to be conclusive. Nevertheless, the observed effects of air pollution are consistent with those described for other chronic respiratory diseases. Exposure to pollution induces oxidative stress, chronic inflammation and shortening of telomeres, which are all mechanisms described in fibrogenesis. New epidemiological studies are needed with individual measurements of exposure to outdoor and indoor pollution, as well as fundamental studies to clarify the effect of pollution on fibrogenesis.
Collapse
Affiliation(s)
- L Sesé
- Service de pneumologie, hôpital Avicenne, AP-HP, Bobigny, France; EPAR, INSERM UMR-S 1136, Sorbonne Université, Paris, France; Service d'explorations fonctionnelles, AP-HP, hôpital Avicenne, Bobigny, France.
| | - F Jeny
- Service de pneumologie, hôpital Avicenne, AP-HP, Bobigny, France; INSERM 1272 « Réponses cellulaires et fonctionnelles à l'hypoxie », Université Paris 13, Bobigny, France
| | - Y Uzunhan
- Service de pneumologie, hôpital Avicenne, AP-HP, Bobigny, France; INSERM 1272 « Réponses cellulaires et fonctionnelles à l'hypoxie », Université Paris 13, Bobigny, France
| | - W Khamis
- Service de pneumologie, hôpital Avicenne, AP-HP, Bobigny, France
| | - O Freynet
- Service de pneumologie, hôpital Avicenne, AP-HP, Bobigny, France
| | - D Valeyre
- Service de pneumologie, hôpital Avicenne, AP-HP, Bobigny, France; INSERM 1272 « Réponses cellulaires et fonctionnelles à l'hypoxie », Université Paris 13, Bobigny, France
| | - J-F Bernaudin
- Service de pneumologie, hôpital Avicenne, AP-HP, Bobigny, France; INSERM 1272 « Réponses cellulaires et fonctionnelles à l'hypoxie », Université Paris 13, Bobigny, France
| | | | - H Nunes
- Service de pneumologie, hôpital Avicenne, AP-HP, Bobigny, France; INSERM 1272 « Réponses cellulaires et fonctionnelles à l'hypoxie », Université Paris 13, Bobigny, France
| |
Collapse
|
7
|
Duchemann B, Didier M, Pailler MC, Brillet PY, Kambouchner M, Uzunhan Y, Freynet O, Chouahnia K, Zelek L, Nunes H. Le nivolumab peut-il être utilisé dans les fibroses pulmonaires idiopathiques ? Rev Mal Respir 2019; 36:209-213. [DOI: 10.1016/j.rmr.2018.11.001] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2018] [Accepted: 08/07/2018] [Indexed: 10/27/2022]
|
8
|
Radu D, Freynet O, Groupe Bippid B. Apport diagnostique et tolérance de la biopsie pulmonaire chirurgicale pour pneumopathie interstitielle diffuse chronique : étude prospective multicentrique (étude BIPPID). Rev Mal Respir 2019. [DOI: 10.1016/j.rmr.2018.10.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
9
|
Chauveau S, Goudot F, Brillet P, Soussan M, Freynet O, Meune C, Valeyre D, Nunes H, Bouvry D. Apport de la discussion multidisciplinaire pour le diagnostic de sarcoïdose cardiaque. Rev Mal Respir 2019. [DOI: 10.1016/j.rmr.2018.10.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
10
|
Catinon M, Busser B, Thivolet F, Kambouchner M, Bernaudin J, Freynet O, Valeyre D, Cavalin C, Rosental P, Sfarghiu A, Arbib F, Pison C, Bonneterre V, Motto-Ros V, Vincent M. Analyse minéralogique par microscopie électronique et par Laser Induced Breakdown Spectroscopy (LIBS) chez deux patients atteints de sarcoïdose issus de l’étude MINASARC. Rev Mal Respir 2018. [DOI: 10.1016/j.rmr.2017.10.268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
11
|
Chemarin C, Catinon M, Cavalin C, Roux E, Rio S, Pecquet M, Blanchet A, Vuillermoz S, Pison C, Arbib F, Bonneterre V, Valeyre D, Freynet O, Mornex J, Freymond N, Pacheco Y, Thivolet F, Kambouchner M, Bernaudin J, Nathalizio A, Rosental P, Vincent M. Analyses minéralogiques de lavages bronchiolo-alvéolaire (LBA) de sujets sains par détection automatique de particules – Intérêt de leur utilisation comme groupe-contrôle dans le cadre de la mise en évidence d’une exposition professionnelle et/ou environnementale. Rev Mal Respir 2017. [DOI: 10.1016/j.rmr.2016.10.728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
12
|
Uzunhan Y, Freynet O, Hervier B, Guyot A, Miyara M, Nunes H. Les manifestations respiratoires au cours des myopathies inflammatoires idiopathiques. Méd Intensive Réa 2016. [DOI: 10.1007/s13546-016-1232-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
13
|
Obert J, Freynet O, Nunes H, Brillet P, Dhote R, Valeyre D, Naccache J. Pronostic des pneumopathies infiltrantes diffuses au cours des myosites. Rev Mal Respir 2014. [DOI: 10.1016/j.rmr.2013.10.122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
14
|
Londner C, Zendah I, Freynet O, Carton Z, Dion G, Nunes H, Valeyre D. Traitement de la sarcoïdose. Rev Med Interne 2011; 32:109-13. [DOI: 10.1016/j.revmed.2010.10.351] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2010] [Accepted: 10/18/2010] [Indexed: 10/18/2022]
|
15
|
Freynet O. Les cellules dendritiques pulmonaires au cours des processus fibrosants- Étude de l’interaction avec les fibroblastes. Rev Mal Respir 2008. [DOI: 10.1016/s0761-8425(08)70482-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
16
|
Bantsimba-Malanda C, Marchal-Sommé J, Freynet O, Crestani B, Soler P. 072 Caractérisation des cellules dendritiques dans la fibrose pulmonaire à la bléomycine chez la souris. Rev Mal Respir 2007. [DOI: 10.1016/s0761-8425(07)74363-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
17
|
Freynet O, Marchal-Sommé J, Bantsimba-Malanda C, Crestani B, Soler P. 065 Les fibroblastes pulmonaires peuvent-ils moduler la maturation des cellules dendritiques in vitro ? Rev Mal Respir 2007. [DOI: 10.1016/s0761-8425(07)74356-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
18
|
Freynet O, Freynet O. 5 SPLF Printemps 2006 (bourse soutenue par Boehringer Ingelheim). Rev Mal Respir 2007. [DOI: 10.1016/s0761-8425(07)91083-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|